CRMD Q1 2026 Earnings Strong EPS Surprise Amidst Limited Revenue Visibility AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage i3 Verticals IIIV Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status Onconetix ONCO Edges Higher Tests Key Resistance at 130 OUTFRONT Media OUT Edges Higher as Support Holds Firm SNDL Inc Holds Steady Near Support Amid Low Volume Epsilon Energy EPSN Holds Steady Near Resistance Amid Modest Decline JetAI Inc Q1 2026 Earnings EPS Misses Estimates as Company Reports Significant Loss